These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


120 related items for PubMed ID: 1026366

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Saralasin test, renal vein renin and unilateral kidney blood flow in renovascular hypertension].
    Helber A, Hummerich W, Bönner G, Meurer KA, Moritz G.
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():208-9. PubMed ID: 613575
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of the renin-angiotensin system in renal hypertension. An experimental approach.
    Helmchen U, Kneissler U.
    Curr Top Pathol; 1976; 61():203-38. PubMed ID: 1248262
    [No Abstract] [Full Text] [Related]

  • 6. Negative saralasin response in correctable renovascular hypertension.
    Trainin EB, Lala VR, Gomez-Leon G, AvRuskin TW.
    J Pediatr; 1978 Sep; 93(3):460-2. PubMed ID: 690764
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Response to saralasin and angiotensin's role in essential and renal hypertension.
    Hollenberg NK, Williams GH, Adams DF, Moore T, Brown C, Borucki LJ, Leung F, Bavli S, Solomon HS, Passan D, Dluhy R.
    Medicine (Baltimore); 1979 Mar; 58(2):115-27. PubMed ID: 431398
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of the angiotensin II blocker 1-Sar-8-Ala-angiotensin II on renal artery clip hypertension in the rat.
    Macdonald GJ, Boyd GW, Peart WS.
    Circ Res; 1975 Nov; 37(5):640-6. PubMed ID: 1192561
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of renal hypertension.
    Brown JJ, Davies DL, Morton JJ, Robertson JI, Cuesta V, Lever AF, Padfield PL, Trust P.
    Lancet; 1976 Jun 05; 1(7971):1219-21. PubMed ID: 58263
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Renovascular disease and saralasin tests.
    Ann Intern Med; 1977 Dec 05; 87(6):790-1. PubMed ID: 931217
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of administration of Sar1-Ala8-angiotensin II during the development and maintenance of renal hypertension in the rat.
    Fernandes M, Fiorentini R, Onesti G, Bellini G, Gould AB, Hessan H, Kim KE, Swartz C.
    Clin Sci Mol Med; 1978 Jun 05; 54(6):633-7. PubMed ID: 657733
    [Abstract] [Full Text] [Related]

  • 17. [Blood pressure behavior following 1-sar-8-ala-angiotensin II (saralasin) in essential and renovascular hypertension].
    Rosenthal J, Franz HE.
    Verh Dtsch Ges Inn Med; 1976 Jun 05; 82 Pt 2():1305-7. PubMed ID: 1029984
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Renin, sodium, and vasodepressor response to saralasin in renovascular and essential hypertension.
    Marks LS, Maxwell MH, Kaufman JJ.
    Ann Intern Med; 1977 Aug 05; 87(2):176-82. PubMed ID: 889198
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.